A baby from Uzbekistan, diagnosed with a metabolic disease that could lead to liver failure, regained health after receiving a liver transplant from ...
Relmada Therapeutics is a late-stage biotechnology company addressing diseases of the central nervous system (CNS) and metabolic disorders. Relmada’s experienced and dedicated team is committed to ...
PRINCETON, N.J., Dec. 09, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery ...
Globally, approximately 58 million people are chronically infected with HCV, resulting in 290,000 annual deaths due to complications such as liver cirrhosis and liver cancer.
Alcohol-related liver disease is one of the most common causes of death worldwide ... Disclaimer: This article, including health and fitness advice, only provides generic information. Don’t treat it ...